Inventor · disambiguated record
Junfa Fan
Also filed as: FAN JUNFA
32 granted patents·6 pending applications·203 citations·filing 2010–2023
97Inventor score
Files withCHEMOCENTRYX INC28BUI MINNA2SUNESIS PHARMACEUTICALS INC2VIRACTA THERAPEUTICS INC2BIOGEN IDEC INC1
Top patents by PatentIndex Score
38 records- 0198US9834545B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2016·Granted Dec 5, 2017·26 cites·33 claims
- 0297US9809581B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2016·Granted Nov 7, 2017·23 cites·29 claims
- 0395US9783540B2Substituted tetrahydropyrans as CCR2 modulatorsCHEMOCENTRYX INC·Filed 2016·Granted Oct 10, 2017·7 cites·45 claims
- 0494US11142521B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Oct 12, 2021·4 cites·6 claims
- 0594US10464934B2Substituted tetrahydropyrans as CCR2 modulatorsCHEMOCENTRYX INC·Filed 2017·Granted Nov 5, 2019·5 cites·13 claims
- 0694US10370363B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2017·Granted Aug 6, 2019·6 cites·13 claims
- 0794US10336736B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2017·Granted Jul 2, 2019·6 cites·24 claims
- 0892US9790229B2Bruton's tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2016·Granted Oct 17, 2017·11 cites·21 claims
- 0992US9169261B2CXCR7 antagonistsCHEMOCENTRYX INC·Filed 2013·Granted Oct 27, 2015·13 cites·26 claims
- 1091US11059825B2CXCR7 antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Jul 13, 2021·2 cites·11 claims
- 1191US10988464B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2019·Granted Apr 27, 2021·3 cites·16 claims
- 1291US8916601B2Aza-aryl 1H-pyrazol-1-YL benzene sulfonamidesCHEMOCENTRYX INC·Filed 2013·Granted Dec 23, 2014·12 cites·20 claims
- 1391US8785440B2Bruton's tyrosine kinase inhibitorsBUI MINNA·Filed 2010·Granted Jul 22, 2014·20 cites·20 claims
- 1490US11040960B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2019·Granted Jun 22, 2021·3 cites·14 claims
- 1590US9758512B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2016·Granted Sep 12, 2017·6 cites·24 claims
- 1689US9249146B2Bruton'S tyrosine kinase inhibitorsBIOGEN IDEC INC·Filed 2014·Granted Feb 2, 2016·9 cites·25 claims
- 1788US8835419B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2012·Granted Sep 16, 2014·9 cites·30 claims
- 1887US9567323B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2014·Granted Feb 14, 2017·6 cites·9 claims
- 1986US10407417B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2017·Granted Sep 10, 2019·3 cites·12 claims
- 2086US9783544B2CXCR7 antagonistsCHEMOCENTRYX INC·Filed 2015·Granted Oct 10, 2017·4 cites·26 claims
- 2185US10596163B2Aza-aryl 1H-pyrazol-1-yl benzene sulfonamidesCHEMOCENTRYX INC·Filed 2018·Granted Mar 24, 2020·3 cites·19 claims
- 2284US9029359B2Heteroaryl Btk inhibitorsBUI MINNA·Filed 2010·Granted May 12, 2015·12 cites·18 claims
- 2384US2024246988A1Bruton's tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2482US10577374B2Bruton's tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2017·Granted Mar 3, 2020·2 cites·18 claims
- 2580US10137120B2Aza-aryl 1H-pyrazol-1-yl benzene sulfonamidesCHEMOCENTRYX INC·Filed 2014·Granted Nov 27, 2018·2 cites·19 claims
- 2678US11884654B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2021·Granted Jan 30, 2024·0 cites·15 claims
- 2778US11834452B2CXCR7 antagonistsCHEMOCENTRYX INC·Filed 2021·Granted Dec 5, 2023·0 cites·14 claims
- 2878US10287292B2CXCR7 antagonistsCHEMOCENTRYX INC·Filed 2017·Granted May 14, 2019·1 cites·7 claims
- 2978US2023046457A1Bruton's tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3077US8853202B2Modulators of CXCR7CHEN XI·Filed 2010·Granted Oct 7, 2014·4 cites·10 claims
- 3176US2022047575A1Aza-aryl 1h-pyrazol-1-yl benzene sulfonamidesCHEMOCENTRYX INC·Filed 2021·Application pending·0 cites
- 3274US12054484B2Substituted tetrahydropyrans as CCR2 modulatorsCHEMOCENTRYX INC·Filed 2021·Granted Aug 6, 2024·0 cites·8 claims
- 3374US11945805B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2021·Granted Apr 2, 2024·0 cites·9 claims
- 3473US11820759B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2021·Granted Nov 21, 2023·0 cites·8 claims
- 3570US2020121688A1Substituted tetrahydropyrans as ccr2 modulatorsCHEMOCENTRYX INC·Filed 2019·Application pending·0 cites
- 3670US2020399283A1Bruton's tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3768US8987284B2Phosphorus containing quinazoline compounds and methods of useSHEN WANG·Filed 2010·Granted Mar 24, 2015·1 cites·24 claims
- 3868US2020197386A1Aza-Aryl 1H-Pyrazol-yl Benzene SulfonamidesCHEMOCENTRYX INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Junfa Fan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →